The images were read by two independent readers blinded to clinical information. In Trial A, 97 adult patients with known or suspected neuroendocrine tumors (NETs) were evaluated with gallium Ga 68 dotatate. The efficacy of NETSPOT was established in three open-label, single center trials (Study A-C). What are the benefits of this drug (results of trials used to assess efficacy)? NETSPOT shows the sites of neuro-endocrine tumors. NETSPOT is injected into a vein (intravenous) in preparation for an imaging test (called positron emission tomography scan or PET scan) to help detect the tumor. NETs are rare tumors that develop in certain hormone-producing cells of the body’s neuro-endocrine system. NETSPOT is a drug for detection of a specific type of tumors called somatostatin receptor positive neuro-endocrine tumors (NETs). NETSPOT (kit for the preparation of gallium Ga 68 dotatate injection)ĭRUG TRIALS SNAPSHOT SUMMARY: What is the drug for? Refer to the NETSPOT (kit for the preparation of gallium Ga 68 dotatate injection) Prescribing Information for complete information. Always speak to your health provider about the risks and benefits of a drug. The Snapshot is intended as one tool for consumers to use when discussing the risks and benefits of the drugs.ĭo not rely on Snapshots to make decisions regarding medical care. The “MORE INFO” bar shows more detailed, technical content for each section. The information provided in Snapshots highlights who participated in the clinical trials that supported the FDA approval of this drug, and whether there were differences among sex, race and age groups.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |